IVUS and OCT Lower MACE in Complex Coronary PCI Better Than Angiography
Complex coronary intervention has long exposed the limits of angiography alone. In lesions where plaque burden, vessel size, bifurcation geometry, calcification, or chronic occlusion distort the lumen silhouette, two-dimensional angiographic images can miss the very features that determine stent expansion and long-term durability. A lesion-level network meta-analysis now places IVUS and OCT ahead of angiography-guided PCI in this setting, with both imaging strategies linked to fewer major adverse cardiovascular events after drug-eluting stent implantation.
The analysis pooled 17 randomized controlled trials and included 13,751 patients with complex coronary lesions undergoing PCI with drug-eluting stents. Investigators compared three guidance strategies across a frequentist random-effects network framework: angiography alone, intravascular ultrasound, and optical coherence tomography. The primary endpoint was MACE, defined as cardiac death, myocardial infarction, or target vessel revascularization. In practical terms, the result speaks to a familiar cath lab problem: when lesion architecture is difficult, direct visualization inside the artery performs better than silhouette-based estimation.
Imaging-Guided PCI Pulled Ahead on the Primary Endpoint
Both imaging modalities reduced the risk of MACE compared with angiography-guided PCI. OCT produced a risk ratio of 0.63 with a 95% confidence interval of 0.55 to 0.72, while IVUS produced a risk ratio of 0.67 with a 95% confidence interval of 0.56 to 0.79. Each comparison was highly significant, with P values below 0.001. Those effect sizes are clinically meaningful because they point to fewer downstream ischemic events, fewer repeat procedures, and less exposure to the hazards that follow incomplete lesion preparation or suboptimal stent deployment.
One sentence captures the central finding plainly: angiography alone was the weakest strategy in complex coronary lesions.
The two imaging modalities did not separate from each other on the primary endpoint. OCT and IVUS were statistically comparable, with a risk ratio of 0.94 and a 95% confidence interval of 0.78 to 1.14; the P value was 0.52. For interventionalists, that equivalence matters because the choice between the two often turns on lesion characteristics, contrast load, catheter availability, and the specific question at hand rather than a clear superiority signal for one device across all complex anatomy.
The Benefit Extended Across the Hardest Lesion Subsets
The consistency of the results across lesion subgroups strengthens the case for intravascular imaging in difficult PCI. The favorable pattern held in chronic total occlusions, left main coronary artery disease, bifurcation lesions, multivessel coronary artery disease, and moderately or severely calcified lesions. These are the situations where angiography is most likely to understate plaque burden, miss stent underexpansion, or fail to define the true vessel diameter and landing zones.
Mechanistically, the advantage is easy to understand. Imaging inside the artery helps operators choose better stent lengths and diameters, identify edge dissection, detect residual plaque and malapposition, and confirm that the final result is mechanically sound. In calcified disease, this becomes especially important because rigid plaque resists expansion and leaves a stent vulnerable to underdeployment. In bifurcations and left main disease, small errors in sizing or placement can have large downstream consequences. In chronic total occlusion, the target vessel often has ambiguous reference segments and diffuse disease, making angiographic estimation especially fragile.
A second sentence stands on its own: the subgroup consistency argues against reserving intravascular imaging for only the most unusual lesions.
Why Intracoronary Imaging Changes the Procedure, Not Just the Picture
The value of IVUS and OCT goes beyond better images. Imaging changes operator behavior in ways that directly affect stent mechanics and vessel healing. It can prompt more aggressive lesion preparation, more precise post-dilation, correction of geographic miss, and additional treatment when residual disease is visible after the initial implant. Those procedural adjustments are the plausible bridge between imaging guidance and fewer events months later.
IVUS and OCT are not identical tools. IVUS offers deeper penetration and tends to perform well in large vessels and heavily calcified disease, while OCT delivers higher-resolution images of the vessel wall and stent struts. Even so, this network meta-analysis did not show a significant difference in clinical efficacy between the two. For bedside decision-making, that means the practical question is often not which modality is universally best, but which one can best answer the anatomical question in front of the operator during a given case.
The finding also reinforces a broader principle in contemporary PCI: the final angiographic appearance is not always enough. A stent can look acceptable on fluoroscopy while remaining underexpanded, eccentric, or edge-dissected. In those cases, intravascular imaging identifies correctable mechanical problems before the patient leaves the laboratory. Fewer mechanical failures at implantation should translate into fewer ischemic events later, and the pooled trial data align with that logic.
What Interventional Practice Should Take From the Trial Pool
Across 13,751 patients, the message is consistent. In complex coronary lesions treated with drug-eluting stents, both IVUS-guided PCI and OCT-guided PCI outperformed angiography-guided PCI for prevention of MACE. The consistency across chronic total occlusion, left main, bifurcation, multivessel, and calcified disease broadens the relevance of the findings well beyond a narrow procedural niche.
The study design still leaves room for caution. This was a network meta-analysis built from randomized controlled trials, not a single head-to-head trial powered specifically to compare IVUS with OCT in every complex lesion category. Network evidence can be strong, but it inherits the structure, quality, and heterogeneity of the underlying trials. Even so, the direction of effect is coherent and clinically intuitive: better lesion definition produces better stent deployment, and better stent deployment produces fewer adverse events.
For cath lab practice, the most defensible interpretation is direct and actionable. When complex coronary anatomy is present and drug-eluting stents are being used, intravascular imaging should not be treated as optional ornamentation. The available randomized evidence supports it as the preferred guidance strategy over angiography alone, while offering no compelling reason to favor OCT over IVUS on the basis of MACE reduction in this analysis.